Fundraising Fox
🦊/Companies
Sign in

Opsidio

Bryn Mawr, US · Delaware LLC · 1 known investors

Find your way into Opsidio

Biotech

Founders & leadership

MD
Martin D. PhillipsNamed on SEC filing
NW
Nicholas W. LukacsNamed on SEC filing
FM
Frank MarcouxNamed on SEC filing
AE
Alan E. CasnoffNamed on SEC filing

Investors · 1

BioAdvanceConshohocken · $500K – $1.5M

Reported raises · per SEC filings

Form D private placements

$800.2K disclosed across 1 round · 2017

▶$800.2KraisedOct 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin D. PhillipsExecutive Officer, Director
  • Nicholas W. LukacsDirector
  • Frank MarcouxDirector
  • Alan E. CasnoffDirector
Offering amount
$1.2M
Amount sold
$800.2K
First sale
Sep 2017
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Opsidio raises $800K to advance new treatment or fibrotic diseases - Philadelphia Business Journalbizjournals.com · Oct 2017Opsidio Closes Bridge Financing to Develop Monoclonal Antibodies to Treat Fibrotic Diseases | Business Wirebusinesswire.com · Sep 2017

Frequently asked questions

Who are Opsidio's investors?
Opsidio's investors include BioAdvance.
How much funding has Opsidio raised?
Opsidio has disclosed $800.2K raised across 1 round.
Where is Opsidio headquartered?
Opsidio is headquartered in Bryn Mawr, US.